次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

眼科用医療機器の世界市場2014-2024年

Ophthalmic Devices Market Forecast 2014-2024
Future Prospects for Leading Companies

出版元:Visiongain(英国)出版元情報LinkIcon
発行年:2014年6月
定価 Single User License(1名様ライセンス) 1,799 GBP(英国ポンド) / Department License(5名様ライセンス) 2,999GBP/ Site License 4,999GBP / Global Site License 6,999GBP
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文192ページになります。
商品コード:VGN256

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
当レポートでは眼科用医療機器の世界市場は2014年に162億9000万ドルに達し、2014年から2024年にかけて堅調な拡大を遂げると予測しています。眼科用医療機器への需要増大、新興経済諸国における医療保険適用の拡大などは売上を促進していくでしょう。成熟市場国、新興市場国、ともに成長が見込まれますが、特にインド、ブラジル、中国、ロシア、韓国においては高い収益成長が続くと見られます。
同市場の2024年に至る市場予測、詳細なセグメント別予測分析に加え、市場動向、研究開発動向、リーディング企業情報などを概略以下の構成でお届けいたします。

【レポート構成概要】
・眼科用医療機器の世界市場予測2014-2024年
・全192ページ、142個のデータ表とグラフ類で分析定量化
・成長率、市場シェア
・業界専門家オピニオンインタビュー:
- Professor Bernard Chang, Consultant Ophthalmologist, Spire Leeds Hospital
- Will Moore, CEO and President, IRIDEX

・セグメント別市場予測2014-2024年VGN256_Ophthalmic Devices Market Forecast 2014-2024 Cover.jpgレポート表紙
<診断とモニタリング>
- オートレフケラトメーター
- OCT(光干渉断層計)
- 眼底カメラ
- スリットランプ
- その他
<手術>
- 眼内レンズ
- 眼科用レーザー
- 超音波水晶体乳化吸引装置
- 眼科粘弾性デバイス
- その他
<ビジョンケア >
- 消耗品
- その他

・主要13ヶ国、国別市場予測2014-2024年
• 米国
• 日本
• フランス
• ドイツ
• イタリア
• スペイン
• 英国
• その他欧州
• ブラジル
• ロシア
• インド
• 中国
• 韓国
• メキシコ
• その他Rest of the World

・リーディング企業10社プロフィール。業績、展望、新製品、提携、合弁など
• Alcon (Novartis)
• Abbott Medical Optics (Abbott)
• Bausch and Lomb (Valeant Pharmaceuticals)
• Johnson and Johnson Vision Care (Johnson and Johnson)
• Nidek
• Hoya Corporation
• STAAR Surgical
• Carl Zeiss AG Meditec
• Topcon Corporation
• Haag-Streit Holding AG

・市場動向
• 世界的な人口高齢化
• 眼疾患の有病率の増加
• 研究開発、臨床開発の予算増額
• 眼科診断機器の高度化
• 米国医療機器物品税の影響

Visiongain is a trading partner with the US Federal Government
【レポート詳細目次は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Ophthalmic Devices Market Forecast 2014-2024
Future Prospects for Leading Companies

Table of Contents

1. Report Overview

1.1 Global Ophthalmic Devices Market Overview
1.2 Global Ophthalmic Devices Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. Introduction to the Ophthalmic Devices Market

2.1 The Eye: An Overview of Its Structure and Function
2.2 The Global Burden of Eye Disease
2.3The Diagnosis and Surgical Treatment for Eye Diseases
2.3.1Refractive errors (Myopia, Hyperopia or Astigmatism)
2.3.1.1 Lasik Eye Surgery (Laser In-Situ Keratomileusis)
2.3.1.2 Phakic Intraocular Surgery
2.3.1.3 Photorefractive keratectomy (PRK)
2.3.1.4 Conductive Keratoplasty (CK)
2.3.1.5 Refractive Lens Exchange (RLE)
2.3.2 Cataracts
2.3.2.1 Phacoemulsification and Intraocular Lens
2.3.2.2 Microincision Cataract Surgery (MICS)
2.3.3 Glaucoma
2.3.3.1 Diagnosis of Glaucoma
2.3.3.2 Glaucoma Surgical Treatment
2.3.4 Age-related Macular Degeneration (AMD)
2.3.4.1 Dry (non-exudative) AMD
2.3.4.1.1 Treatment for Dry AMD
2.3.4.2 Wet (exudative) AMD
2.3.4.3 Surgical Treatment of Wet AMD
2.3.4.3.1 Photodynamic Therapy
2.3.4.3.2 Laser Photocoagulation
2.3.4.3.3 Radiotherapy
2.3.4.3.4 Newer Types of Surgery
2.3.4.3.5 Wet AMD: Poor Outcomes with Surgical Procedures
2.3.5 Diabetic Retinopathy (DR)
2.3.5.1 Diagnosis of Diabetic Retinopathy
2.3.5.2 Treatment of Diabetic Retinopathy
2.3.6 Dry Eye Syndrome
2.3.6.1 Treatment of Dry Eye Syndrome
2.3.6.1.1 Punctal Occlusion
2.3.6.1.2 Salivary Gland Autotransplantation
2.4 Ophthalmic Devices
2.4.1 What are Ophthalmic Devices?
2.4.2 Devices: Classification
2.4.2.1 The US Medical Devices Classification System
2.4.2.2 The EU Medical Devices Classification System
2.4.3 Regulation of Ophthalmic Devices
2.4.3.1 The US Approval and Regulation System
2.4.3.2 The EU Approval and Regulation System
2.4.3.3 The Japanese Approval and Regulation System
2.5 Ophthalmic Devices: Market Segmentation
2.5.1 The Monitoring and Diagnostics Ophthalmic Devices Market
2.5.1.1 General Eye Health
2.5.1.2 Refractive Error Monitoring and Diagnostics Devices
2.5.1.3 Glaucoma Monitoring and Diagnostic Devices
2.5.2 The Surgical Ophthalmic Devices Market
2.5.2.1 Cataract Surgery Devices
2.5.2.2 Glaucoma Surgery Devices
2.5.2.3 Refractive Error Surgery Devices
2.5.2.4 Vitreoretinal Surgery Devices
2.5.3 The Vision Care Devices Market

3. The Ophthalmic Devices Market, 2014-2024

3.1 The Medical Devices Market Overview
3.1.1 The Medical Devices Market, 2013
3.1.2 The Medical Devices Market, 2014-2024
3.2 The Ophthalmic Devices Market by Submarket, 2013
3.3 The Ophthalmic Devices Market, 2014-2024

4. The Ophthalmic Vision Care Devices Market, 2014-2024

4.1 The Ophthalmic Vision Care Devices Market Overview
4.2 The Ophthalmic Vision Care Devices Market, 2014-2024
4.2.1 The Ophthalmic Vision Care Devices Market by Segment
4.2.1.1 The Ophthalmic Vision Care Devices Market by Segment, 2013
4.2.1.2 The Ophthalmic Vision Care Devices Market by Segment, 2014-2024
4.2.1.2.1 The Daily Disposable Contact Lenses Market, 2014-2024
4.2.1.2.2 The Other Contact Lenses Market, 2014-2024
4.3 Contact Lenses on the Market
4.4 The Contact Lenses Market: New Product Development and Product Pipeline
4.4.1 Clariti® 1 Day (Sauflon)
4.4.2 MyDay™ Daily Disposable Lenses (CooperVision)
4.4.3 1-DAY ACUVUE® TruEye® (Johnson & Johnson Vision Care)
4.4.4 Biotrue™ ONEday Contact Lenses (Bausch and Lomb)
4.4.5 Anti Microbial Contact Lenses (Brien Holden Vision Institute and School of
Optometry and Vision Science, University of New South Wales)
4.5 SWOT Analysis of the Vision Care Market, 2014-2024
4.5.1 Strengths
4.5.1.1 Silicone Hydrogels have Revolutionised Contact Lenses
4.5.1.2 Greater Use of Disposable Contact Lenses
4.5.2 Weaknesses
4.5.2.1 High Entry Barriers for New Entry Manufacturers
4.5.2.2 Fast Downward Pricing Pressure
4.5.2.3 Hygiene Issues
4.5.2.4 Greater Susceptibility to Global Recession
4.5.3 Opportunities
4.5.3.1 Growing Affluent Population in Emerging Economies
4.5.3.2 Contact Lenses Used as Diagnostic Tools
4.5.3.3 Sale of Cosmetic and Coloured Lenses
4.5.4 Threats
4.5.4.1 Growing Demand for Lasik Surgery

5. The Ophthalmic Diagnostics and Monitoring Devices Market, 2014-2024

5.1 The Ophthalmic Diagnostics and Monitoring Devices Market Overview
5.2 The Ophthalmic Diagnostics and Monitoring Devices Market, 2013
5.3 The Ophthalmic Diagnostics and Monitoring Devices Market by Segment, 2014-2024
5.4 The Autorefractor/Keratometer Market, 2014-2024
5.5 The Fundus Camera Market, 2014-2024
5.6 The Slit Lamp Market, 2014-2024
5.7 The OCT Machine Market, 2014-2024
5.7.1 Ophthalmic OCT Machine Products
5.8 The Other Ophthalmic Diagnostics and Monitoring Devices Market, 2014-2024
5.9 Diagnostic Pipeline
5.9.1 Diagnostics and Monitoring Contact Lenses
5.9.1.1 Sensimed (Triggerfish)
5.9.1.2 Pro-IOP eye pressure sensor (Implandata Ophthalmic Products GmbH)
5.9.1.3 Glucose Monitoring Contact Lens (Google)
5.10 SWOT Analysis of the Ophthalmic Diagnostic and Monitoring Devices Market, 2014-2024
5.10.1 Strengths
5.10.1.1 Increasing Sophistication of Ophthalmic Diagnostic Devices
5.10.2 Weaknesses
5.10.2.1 Shortage of Ophthalmic Device Providers
5.10.3 Opportunities
5.10.3.1 Ageing Population
5.10.3.2 Increasing Demand for Advanced Optical Coherence Tomography
Machines
5.10.3.3 Increasing Demand for Advanced Ophthalmic Diagnostic Devices in
Emerging Markets
5.10.4 Threats
5.10.4.1 Increasing Cost of Healthcare
5.10.4.2 US Medical Device Excise Tax

6. The Ophthalmic Surgical Devices Market, 2014-2024

6.1 The Ophthalmic Surgical Devices Market Overview
6.1.1 The Surgical Ophthalmic Devices Market, 2013
6.1.2 The Surgical Ophthalmic Devices Market, 2014-2024
6.2 The Intraocular Lenses Market, 2014-2024
6.2.1 Intraocular Lenses Products
6.2.2 Intraocular Lenses Product Pipeline
6.2.2.1 Smart IOL (Medennium)
6.2.2.2 NuLens Accommodating IOL (NuLens)
6.2.2.3 Flex Optic IOL (Quest Vision/AMO)
6.2.2.4 Zephyr (Anew Optics)
6.2.2.5 The FluidVision Lens (PowerVision)
6.2.2.6 Superior Accommodating IOL (HumanOptics)
6.2.2.7 KAMRA Vision (Acufocus)
6.3 The Ophthalmic Laser Market, 2014-2024
6.3.1 Laser System Products
6.3.1.1Refractive Lasers
6.3.1.2 STAR S4 IR™ Excimer Laser (Abbott Medical Optics)
6.3.1.3 WaveLight® Allegretto Wave® Eye-Q Laser (Alcon)
6.3.1.4 NIDEK Advanced Vision Excimer Laser System NAVEX Quest (Nidek)
6.3.1.5 TECHNOLAS® TENEO™ 317 Laser (Bausch and Lomb Technolas)
6.3.2 Cataract Lasers
6.3.2.1 The LenSx Laser (Alcon)
6.3.2.2 LENSAR Laser System (LENSAR)
6.3.2.3 Catalys Precision Laser System (Abbott Medical Optics)
6.3.2.4 VICTUS Femtosecond Laser Platform (Bausch and Lomb Technolas)
6.3.2.5 Lumenis Vision (InSight)
6.4 The Phacoemulsification Device Market, 2014-2024
6.5 The Ophthalmic Viscoelastic Device Market, 2014-2024
6.6 The Other Surgical Ophthalmic Devices Market, 2014-2024
6.7 Ophthalmic Drug Delivery Devices
6.7.1 Recent Approvals
6.7.1.1 Vitrasert® ganciclovir 4.5mg (Bausch + Lomb)
6.7.1.2 Retisert® fluocinolone acetonide (Bausch + Lomb)
6.7.1.3 Ozurdex® dexamethasone (Allergan)
6.7.1.4 Iluvien® fluocinolone acetonide (Alimera Sciences)
6.7.2 Novel Ocular Drug Delivery Platform Pipeline
6.7.2.1 ECT Platform (Neurotech Pharmaceuticals)
6.7.2.2 SynBiosys® Polymer Platform (InnoCore)
6.7.2.3 Hydrogel Technology Products (Ocular Therapeutix)
6.7.2.4 Helios Ocular (ForSight Vision5)
6.7.2.5 L-PPDS Drug Delivery System (Mati Therapeutics)
6.8 Microinvasive Glaucoma Surgery (MIGS)
6.8.1 MIGS Product Approvals
6.8.1.1 Trabectome (NeoMedix Corporation)
6.8.1.2 EX-PRESS Glaucoma Filtration Devices (Alcon)
6.8.1.3 iStent (Glaukos)
6.8.2 Stents in the Glaucoma Pipeline
6.8.2.1 CyPass Micro-Stent (Transcend Medical)
6.8.2.2 Hydrus (Ivantis)
6.8.2.3 XEN Gel Stent (Aquesys)
6.9 Other Ophthalmic Surgical Devices in Development
6.9.1 Argus II Retinal Implant (Second Sight)
6.9.2 Alpha IMS (Retina Implant AG)
6.10 SWOT Analysis of the Ophthalmic Surgical Devices Market, 2014-2024
6.10.1 Strengths
6.10.1.1 Highest Growing Submarket
6.10.1.2 Fast Development of IOL Technology
6.10.1.3 Increasingly Sophisticated Laser Surgery
6.10.2 Weaknesses
6.10.2.1 Extended FDA Timelines
6.10.2.2 Challenging Reimbursement Environment
6.10.3 Opportunities
6.10.3.1 Ageing Population
6.10.3.2 Rising Diabetes Epidemic
6.10.3.3 Large Pipeline of Products
6.10.4 Threats
6.10.4.1 Venture Capital Available to Support Early Stage Companies is
Trending Down
6.10.4.2 Pharmaceuticals Compete as Therapies for Ocular Diseases
6.10.4.3 US Medical Device Excise Tax

7. The Leading National Ophthalmic Devices Markets, 2014-2024

7.1 The Leading National Ophthalmic Devices Market, 2013
7.1.1 The Leading National Ophthalmic Devices Market Forecast, 2014-2024
7.2 The US Ophthalmic Devices Market Forecast, 2014-2024
7.3 The European Ophthalmic Devices Market, 2013
7.3.1 The European Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.1 The German Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.2 The French Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.3 The Italian Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.4 The Spanish Ophthalmic Devices Market Forecast, 2014-2024
7.3.1.5 The UK Ophthalmic Devices Market Forecast, 2014-2024
7.4 The Japanese Ophthalmic Devices Market Forecast, 2014-2024
7.5 The Brazilian Ophthalmic Devices Market Forecast, 2014-2024
7.6 The Russian Ophthalmic Devices Market Forecast, 2014-2024
7.7 The Indian Ophthalmic Devices Market Forecast, 2014-2024
7.8 The Chinese Ophthalmic Devices Market Forecast, 2014-2024
7.9 The South Korean Ophthalmic Devices Market Forecast, 2014-2024
7.10 The Mexican Ophthalmic Devices Market Forecast, 2014-2024

8. The Leading Ophthalmic Devices Companies, 2014-2024

8.1 Alcon (Acquired by Novartis)
8.1.1 Recent Financial Performance, 2012-2013
8.1.1.1 Surgical Segment: Financial Performance, 2012-2013
8.1.1.2 Vision Care Segment: Financial Performance, 2012-2013
8.1.2 Product Line
8.1.2.1 Surgical Products
8.1.2.1.1 The CENTURION® Vision System
8.1.2.1.2 LenSx® Laser
8.1.2.1.3 The WaveLight® Refractive Suite
8.1.2.1.4 The WaveLight® Allegretto Wave® Eye-Q Laser
8.1.2.1.5 ACRYSOF® IOLS
8.1.2.1.6 The EX-PRESS® Glaucoma Filtration Device
8.1.2.2 Vision Care Products
8.1.2.2.1 AIR OPTIX®
8.1.2.2.2 FOCUS DAILIES
8.1.3 Mergers and Acquisitions
8.1.3.1 Novartis Acquisition of Alcon
8.1.3.2 Acquisition of Endure Medical Systems
8.1.3.3 Acquisition of SensoMotoric Instruments GmbH (SMI) – Ophthalmic
Division
8.1.3.4 Acquisition of LenSx Lasers
8.1.4 Jobs Losses
8.2 Abbott Medical Optics (AMO)
8.2.1 AMO Financial Performance, 2012-2013
8.2.2 AMO Product Portfolio
8.2.3 Mergers and Acquisitions
8.2.3.1 Abbott’s Acquisition of Advanced Medical Optics
8.2.3.2 Acquisition of OptiMedica
8.2.3.3 Acquisition of VISX
8.3 Bausch and Lomb (B+L) (acquired by Valeant)
8.3.1 Bausch and Lomb Financial Performance, 2008-2012
8.3.1.1 Bausch and Lomb Financial Performance by Segment, 2010-2012
8.3.2 Mergers and Acquisitions
8.3.2.1 Acquisition of Laboratorio Pförtner Cornealent SACIF
8.3.2.2 Valeant’s Acquisition of Bausch and Lomb
8.3.2.3 Acquisition of Technolas Perfect Vision GmbH
8.3.2.4 Acquisition of Eyeonics
8.3.3 Bausch and Lomb’s Price Fixing in China
8.4 Johnson & Johnson Vision Care
8.4.1 Johnson and Johnson Vision Care Financial Performance, 2013
8.4.1.1 Johnson and Johnson Vision Care Financial Performance, 2011- 2013
8.4.2 J&J Vision Care Product Portfolio
8.4.3 Vistakon Expansion of Manufacturing Facilities
8.4.3.1 Johnson and Johnson Fined for Price Fixing Contact Lens in China
8.5 Nidek
8.5.1 Nidek Financial Performance, 2008-2012
8.5.2 Leading Product lines
8.5.2.1 Surgical Systems
8.5.2.2 Intraocular Lens
8.5.2.3 Ophthalmic Lasers
8.5.2.4 Refractive Surgery Systems
8.5.2.5 Diagnostic Equipment
8.6 Hoya Corporation
8.6.1 Hoya Financial Performance, 2007-2013
8.6.1.1 Hoya Financial Performance by Business Segment, 2013
8.6.2 Hoya IOL Product Line
8.7 STAAR Surgical (STAAR)
8.7.1 STAAR Surgical Financial Performance, 2009-2013
8.7.2 STAAR: Revenue by Region, 2013
8.7.3 STAAR: Revenue by Segment, 2011-2013
8.7.4 STAAR: Product Line
8.7.4.1 Intracollamer Lenses
8.7.4.2 Intraocular Lenses
8.8 Carl Zeiss AG Meditec
8.8.1 Carl Zeiss Meditec Revenue Financial Performance, 2012-2013
8.8.2 Carl Zeiss Meditec Revenue by Business Unit, 2012-2013
8.8.3 Carl Zeiss Meditec Revenue by Region, 2013
8.8.4 Carl Zeiss Meditec Product Line
8.8.5 Mergers and Acquisitions
8.8.5.1 Acquisition of Aaren Scientific
8.9 TopCon
8.9.1 TopCon: Revenue by Company, 2013
8.9.2 TopCon: Major Ophthalmic Devices Products
8.9.2.1 3D OCT-2000 Spectral Domain OCT
8.9.2.2 Other Major Products
8.9.3 Mergers and Acquisitions
8.9.3.1 Acquisition of Optimedica’s Retina and Glaucoma Business
8.10 Haag-Streit Holding AG
8.10.1 Haag-Streit Holding AG Product Line

9. Qualitative Analysis of the Ophthalmic Devices Market 2014-2024

9.1 Porter’s Five Forces Analysis of the Ophthalmic Devices Market
9.1.1 Rivalry Among Competitors [High]
9.1.2 Threat of New Entrants [Medium]
9.1.3 Power of Suppliers [Low]
9.1.4 Power of Buyers [High]
9.1.5 Threat of Substitutes (High)

10. Expert Opinion

10.1 Professor Bernard Chang, Consultant Ophthalmologist, Spire Leeds Hospital
10.1.1 The Evolution of Diagnostic and Surgical Ophthalmic Devices
10.1.2 The Needs for Advancement in Ophthalmic Therapy
10.1.3 Ophthalmic Diseases Indications and the Use of Surgery as Therapy
10.1.4 Reimbursement of Ophthalmic Devices
10.1.5 The Regulatory Concerns for Ophthalmic Devices
10.2 Will Moore, CEO and President, IRIDEX
10.2.1 M&A Increases in the Ophthalmic Devices Market
10.2.2 Iridex’s Business Strategy
10.2.3 Iridex’s Regional Sales Focus
10.2.4 High Revenue Generating Products
10.2.5 Iridex’s Pipeline Products

11. Conclusions

11.1 The World Ophthalmic Devices Market, 2013-2014
11.2 Leading Ophthalmic Devices Submarkets
11.3 World Ophthalmic Devices Market Forecast, 2014-2024
11.4 Leading Segments of the Ophthalmic Devices Submarkets

List of Tables

Table 2.1 Segments and Definitions of the Ophthalmic Market
Table 2.2 ICD 10 Classification of Visual Impairment, 2010
Table 2.3 The US Classification of Medical Devices
Table 2.4 The EU Classification of Medical Devices
Table 3.1 The Global Medical Devices Market: Revenue ($bn), Market Share (%) by Sector, 2013
Table 3.2 The Global Medical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 3.3 Submarkets of the Ophthalmic Devices Market: Revenue ($bn), Market Share (%),
2013
Table 3.4 The Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.1 The Vision Care Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.2 The Ophthalmic Vision Care Devices Market: Revenue ($bn), Market Share (%) by Segment, 2013
Table 4.3 The Ophthalmic Vision Care Devices Market: Revenue ($bn), AGR (%), CAGR (%) by Segment, 2013-2024
Table 4.4 The Daily Disposable Contact Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.5 The Other Contact Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 4.6 Leading Silicone Hydrogel Contact Lenses Products in the Market, 2014
Table 4.7 SWOT Analysis of the Vision Care Devices Market , 2013-2024
Table 5.1 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), Market Shares (%) by Segment, 2013
Table 5.2 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%),CAGR (%) by Segment, 2013-2024
Table 5.3 The Autorefractor/Keratometer Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.4 The Fundus Camera Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.5 The Slit Lamp Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.6 The OCT Machine Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.7 Leading Ophthalmic OCT Machines in the Market, 2014
Table 5.8 The Other Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 5.9 SWOT Analysis of the Ophthalmic Diagnostics and Monitoring Devices Market , 2013-2024
Table 6.1 The Ophthalmic Surgical Devices Market: Revenue ($bn), Market Share (%) by
Segment, 2013
Table 6.2 The Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.3 The Intraocular Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.4 The Types of Premium IOLs on the Market, 2014
Table 6.5 The Ophthalmic Laser Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.6 The Phacoemulsification Device Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.7 The Ophthalmic Viscoelastic Device Market: Revenue ($bn), AGR (%), CAGR (%),
2013-2024
Table 6.8 The Other Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 6.9 SWOT Analysis of the Ophthalmic Surgical Devices Market, 2013-2024
Table 7.1 The Ophthalmic Devices Market: Revenue ($bn), Market Share (%) by Region, 2013
Table 7.2 The Leading National Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.3 The US Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.4 The European Ophthalmic Devices Market: Revenue ($bn), Market Share (%) by
Country, 2013
Table 7.5 The European Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%) by Country, 2013-2024
Table 7.6 The German Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.7 The French Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.8 The Italian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.9 The Spanish Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.10 The UK Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.11 The Japanese Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.12 The Brazilian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%),
2013-2024
Table 7.13 The Russian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.14 The Indian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.15 The Chinese Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.16 The South Korean Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 7.17 The Mexican Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Table 8.1 Alcon: Revenue ($m), AGR (%) by Segment, 2011-2013
Table 8.2 Alcon Surgical Segment: Revenue ($m), AGR (%) by Subsegment, 2012-2013
Table 8.3 Alcon Vision Care Segment: Revenue ($m), AGR (%) by Subsegment, 2012-2013
Table 8.4 Abbott Medical Devices: Revenue ($m), AGR (%) by Segment, 2012-2013
Table 8.5 Abbott Medical Devices: Product Line, 2014
Table 8.6 Bausch and Lomb: Revenue ($m), AGR (%), 2008-2012
Table 8.7 Bausch and Lomb: Revenue ($m), AGR (%) by Segment, 2010-2012
Table 8.8 J&J Medical Devices and Diagnostics: Revenue ($bn), Revenue Share (%) by Segment, 2013
Table 8.9 J&J Vision Care: Revenue ($m), AGR (%), 2011-2013
Table 8.10 J&J Vision Care: Product Line by Wear Time, 2014
Table 8.11 J&J Vision Care: Product Line by Type of Refractive Error, 2014
Table 8.12 Nidek: Revenue ($m), AGR (%), CAGR (%), 2008-2012
Table 8.13 Hoya: Revenue ($m), AGR (%), CAGR (%), 2007-2013
Table 8.14 STAAR: Revenue ($m), AGR (%), CAGR (%), 2009-2013
Table 8.15 STAAR: Revenue ($m), Revenue Share (%) by Region, 2013
Table 8.16 STAAR: Revenue ($m), AGR (%) by Segment, 2011-2013
Table 8.17 STAAR: Product line
Table 8.18 Carl Zeiss Meditec: Revenue ($m), AGR (%), 2012-2013
Table 8.19 Carl Zeiss Meditec: Revenue ($m), AGR (%) by Business Unit, 2012-2013
Table 8.20 Carl Zeiss Meditec: Revenue ($m), Revenue Share (%) by Region, 2013
Table 8.21 Carl Zeiss Meditec: Ophthalmic Product Line
Table 8.22 TopCon: Revenue ($m), Revenue Share (%) by Company, 2013
Table 8.23 Haag-Streit: Medical Technology & Specialities

List of Figures

Figure 1.1 The Global Over 65 Population: Forecast (millions, AGR%), 2013-2024
Figure 1.2 Ophthalmic Devices: Overview of Submarkets and Devices
Figure 2.1 Structure of the Human Eye
Figure 2.2 Estimated Global Prevalence of Visual Impairment (millions of people), 2013
Figure 2.3 Global Causes of Visual Impairment (% of cases), 2013
Figure 3.1 The Medical Device Market: Market Shares (%) by Sector, 2013
Figure 3.2 The Global Medical Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 3.3 Submarkets of the Ophthalmic Devices Market: Revenue ($bn), 2013
Figure 3.4 Submarkets of the Ophthalmic Devices Market: Market Share (%), 2013
Figure 3.5 The Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 4.1 The Ophthalmic Vision Care Devices Market: Market Share (%) by Company, 2013
Figure 4.2 The Vision Care Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2013-2024
Figure 4.3 The Ophthalmic Vision Care Devices Market: Revenue ($bn) by Segment, 2013
Figure 4.4 The Ophthalmic Vision Care Devices Market: Market Share (%) by Segment, 2013
Figure 4.5 The Ophthalmic Vision Care Devices Market: Revenue ($bn) by Segment, 2013-2024
Figure 4.6 The Daily Disposable Contact Lenses Market: Revenue ($bn), AGR (%), 2013-2024
Figure 4.7 The Other Contact Lenses Market: Revenue ($bn), AGR (%), 2013-2024
Figure 5.1 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn) by Segment,
2013
Figure 5.2 The Ophthalmic Diagnostics and Monitoring Devices Market Forecast: Market Share (%) by Segment, 2013
Figure 5.3 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%), 2013-2024
Figure 5.4 The Autorefractor/Keratometer Market: Revenue ($bn), AGR (%), 2013-2024
Figure 5.5 The Fundus Camera Market: Revenue ($bn), AGR (%), 2013-2024
Figure 5.6 The Slit Lamp Market: Revenue ($bn), AGR (%), 2013-2024
Figure 5.7 The OCT Machine Market: Revenue ($bn), AGR (%), 2013-2024
Figure 5.8 The Other Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%), 2013-2024
Figure 6.1 The Ophthalmic Surgical Devices Market: Revenue ($bn) by Segment, 2013
Figure 6.2 The Ophthalmic Surgical Devices Market: Market Share (%) by Segment, 2013
Figure 6.3 The Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 6.4 The Intraocular Lenses Market: Revenue ($bn), AGR (%), 2013-2024
Figure 6.5 The Ophthalmic Laser Market: Revenue ($bn), AGR (%), 2013-2024
Figure 6.6 The Phacoemulsification Device Market: Revenue ($bn), AGR (%), 2013-2024
Figure 6.7 The Ophthalmic Viscoelastic Device Market: Revenue ($bn), AGR (%), 2013-2024
Figure 6.8 The Other Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 6.9 Neurotech: Encapsulated Cell Technology Pipeline, 2014
Figure 6.10 Ocular Therapeutix: Punctum Plug Sustained Release Pipeline, 2014
Figure 7.1 The Ophthalmic Devices Market: Market Share (%) by Region, 2013
Figure 7.2 The US Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.3 The European Ophthalmic Devices Market: Revenue ($bn) by Country, 2013
Figure 7.4 The European Ophthalmic Devices Market: Market Share (%) by Country, 2013
Figure 7.5 The European Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.6 The German Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.7 The French Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.8 The Italian Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.9 The Spanish Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.10 The UK Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.11 The Japanese Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.12 The Brazilian Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.13 The Russian Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.14 The Indian Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.15 The Chinese Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 7.16 The South Korean Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-
2024
Figure 7.17 The Mexican Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2013-2024
Figure 8.1 Alcon: Revenue Share (%) by Segment, 2013
Figure 8.2 Alcon Surgical Segment: Revenue Share (%) by Subsegment, 2013
Figure 8.3 Alcon Vision Care Segment: Revenue Share (%) by Subsegment, 2013
Figure 8.4 Abbott Medical Devices: Revenue Share (%) by Segment, 2013
Figure 8.5 Bausch and Lomb: Revenue ($m), AGR (%), 2008-2012
Figure 8.6 Bausch and Lomb: Revenue Share (%) by Segment, 2012
Figure 8.7 Nidek: Revenue ($m), AGR (%), 2008-2012
Figure 8.8 Hoya: Revenue ($m), AGR (%), 2007-2013
Figure 8.9 Hoya: Revenue Share (%) by Segment, 2013
Figure 8.10 STAAR: Revenue ($m), AGR (%), 2009-2013
Figure 8.11 STAAR: Revenue Share (%) by Region, 2013
Figure 8.12 STAAR: Revenue Share (%) by Product, 2013
Figure 8.13 Carl Zeiss Meditec: Revenue Share (%) by Business Unit, 2013
Figure 8.14 Carl Zeiss Meditec: Revenue Share (%) by Region, 2013
Figure 8.15 TopCon: Revenue Share (%) by Company, 2013
Figure 9.1 Porter’s Five Forces Analysis of the Ophthalmic Devices Market, 2014-2024
Figure 11.1 World Ophthalmic Devices Market: Revenue ($bn) by Submarket, 2013-2014
Figure 11.2 World Ophthalmic Devices Market: Revenue ($bn), 2013-2024

掲載企業リスト

Companies Listed

Aaren Scientific
Abbott Medical Optics
Acufocus
Alcon (acquired by Novartis)
Alimera Sciences
Allergan
Anew Optics
Aquesys
Bausch and Lomb (acquired by Valeant)
Bausch and Lomb Technolas
Canon
Carl Zeiss AG Meditec
CIBA Vison
CooperVision
Endure Medical Systems
Eyeonics
ForSight Vision5
Forus Health
Genentech
Glaukos
Google
Haag-Streit
Heidelberg Engineering
Hoya
HumanOptics
Implandata Ophthalmic Products GmbH
InnoCore Pharmaceuticals
InSight
Iridex
Ivantis
Johnson & Johnson Vision Care
LENSAR
LenSx Lasers
Lumenis
Mati Therapeutics
Medennium
NeoMedix Corporation
Nestlé
Neurotech Pharmaceuticals
Nidek
Novartis
NuLens
Ocular Therapeutix
OPHTEC
OptiMedica
Optovue
OSI Pharmaceuticals
PowerVision
Quest Vision
Regeneron
Retina Implant AG
Sauflon
Second Sight
SensoMotoric Instruments
STAAR Surgical
Tomey
TopCon
Transcend Medical
Triggerfish
Valeant
Vistakon (Johnson & Johnson Vision Care)
VISX

Other Organisations Mentioned in this Report

A* Star Institute for Infocomm Research
Brein Holden Vision Institute and School of Optometry and Vision Science, University of New South Wales
Center for Disease Control and Prevention (CDC) (US)
International Diabetes Federation
National Competent Authorities (NCAs) of Member States
National Institute of Statistics and Geography (INEGI) (Mexico)
The Food and Drug Administration (FDA) (US)
The Japanese Ministry of Health, Labour, and Welfare (MHLW)
The Leeds Teaching Hospitals NHS Trust
The National Institute of Clinical Excellence (NICE)
The Pharmaceutical and Medical Devices Agency (PMDA)
The US Preventive Services Task Force (USPSTF)
U.S. Center for Medicare and Medicaid Services (CMS)
United Nations (UN)
World Health Organisation (WHO)

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

関連レポート紹介

眼科薬の世界市場2014-2024年

当レポートでは眼科薬の世界市場は2014年に209億ドルに達すると推計しており、2024年にかけて堅調な売上増を予測しています。眼科薬への需要増大、医療保険適用の拡大、研究開発(R&D)パイプラインの充実やドラッグデリバリー技術の進歩などは、市場成長の促進要因となっています。

レポートページへLinkIcon

2319881.jpg国内外のスマートグリッド関連ニュース、リサーチ情報等を収集し隔週でお届けいたします。日本そして海外の企業動向、新製品、政府支援、技術開発、規格、導入事例、投資、調査発表など幅広く情報を定期配信いたします。
スマートグリッド・ニュースへLinkIcon


ニュースページへLinkIcon

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。